权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Staff Investigators

职员调查员

基本信息

批准号：
7944900
负责人：
ROBERT B. DIASIO
金额：
$ 3.58万
依托单位：
MAYO CLINIC ROCHESTER
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-04-17 至 2014-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7944900
关键词：
6-Mercaptopurine Ablation American Angiogenesis Inhibitors Antibodies Appointment Aromatase Inhibitors Autologous Award B7-DC antigen Basic Science Biological Markers Blood donor Calendar Cancer Center Cancer Vaccines Carboplatin Cells Childhood Leukemia Clinic Clinical Clinical Investigator Clinical Pharmacology Clinical Research Clinical Trials Collaborations Comprehensive Cancer Center Cytotoxic T-Lymphocytes DNA Data Defect Dendritic Cells Dermatology Development Developmental Therapeutics Program Disease Doctor of Philosophy Enzymes Faculty Failure Funding General Hospitals Genetic Polymorphism Gold Grant Granulocyte-Macrophage Colony-Stimulating Factor Heat shock proteins Heating Hematologist Hematology Hormones Human Immune Immunity Immunization Immunologic Adjuvants Immunology Immunotherapeutic agent Immunotherapy In Situ Individual Inherited Injection of therapeutic agent Internal Medicine Internship and Residency Joints Kansas Laboratories Leadership Lesion Life Liver Lung Malignant Neoplasms Malignant neoplasm of pancreas Malignant neoplasm of prostate Massachusetts Mayo Clinic Cancer Center Medicine Mentors Metastatic Melanoma Molecular National Human Genome Research Institute National Institute of General Medical Sciences Nature North Central Cancer Treatment Group Oncologist Operative Surgical Procedures Paclitaxel Patients Peptide Vaccines Peptides Pharmaceutical Preparations Pharmacogenetics Pharmacogenomics Pharmacology Phase I Clinical Trials Phase III Clinical Trials Physicians Plasma Positioning Attribute Principal Investigator Publishing Radiofrequency Interstitial Ablation Randomized Reproduction spores Research Research Activity Research Personnel Resource Sharing Resources Role Sampling Scientific Advances and Accomplishments Scientist Series Societies Study Section Techniques Testing Therapeutic Therapeutic Agents Time Toxic effect Training Translating Translations Tumor Bank Tumor Immunity United States National Institutes of Health Universities Vaccine Clinical Trial Vaccines Variant Veins Wages Woman Work aerosolized anastrozole base bevacizumab cancer immunotherapy career crosslink drug metabolism editorial genome wide association study immunogenic in vivo malignant breast neoplasm melanoma member novel novel strategies novel therapeutics oncology outcome forecast peripheral blood preclinical study professor programs research clinical testing response thiopurine thiopurine methyltransferase trait tumor tumor immunology tumor progression working group

项目摘要

The Mayo Clinic Cancer Center (MCCC) is requesting partial salary support for two Staff Investigators. Neither of these two individuals has a leadership position within the Center, its programs, or its shared resources. Both of these Staff Investigators, however, are judged to be critical by the MCCC leadership to the operation of the Cancer Center for different reasons. One investigator is a physician-scientist with a major basic scientific role in the Center, providing expertise in pharmacogenomics that is a research direction of the Developmental Therapeutics Program and is important as a Staff Investigator determining newer approaches as to how to use therapeutic agents in various disease states; e.g., the Women's Cancer Program. The second investigator is a physician-scientist who has both a clinical role and a basic science role as a Staff Clinical Investigator in the Immunology and Immunotherapy Program. Most important, however, is that he has been a valuable translational scientist facilitating the studies of both basic scientists and clinicians.

马约诊所癌症中心（MCCC）要求为两名工作人员提供部分工资支持 Investigators.这两个人都没有在中心担任领导职务，程序或其共享资源。然而，这两名工作人员调查员被认为是 MCCC领导层出于各种原因对癌症中心的运作提出了批评。一研究者是一名医生-科学家，在中心发挥主要的基础科学作用，药物基因组学的专业知识，这是发展治疗学的研究方向作为一名研究人员，确定如何使用新的方法是很重要的用于各种疾病状态的治疗剂;例如，妇女癌症项目第二研究者是一名医生-科学家，作为工作人员，既有临床角色，也有基础科学角色免疫学和免疫治疗项目的临床研究员。然而，最重要的是，他是一位有价值的转化科学家，促进了基础科学家和临床医生